Effectiveness of galactose-based intravenous contrast medium on color doppler sonography of deeply located hepatocellular carcinoma
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Japanese Journal of Clinical Oncology
- Vol. 21 (2), 157-160
- https://doi.org/10.1016/s0301-5629(94)00122-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Galactose-based intravenous sonographic contrast agent: experimental studiesJournal of Ultrasound in Medicine, 1993
- Contrast-enhanced transcranial color-coded real-time sonography. Results of a phase-two study.Stroke, 1993
- Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles.Radiology, 1993
- Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results.American Journal of Roentgenology, 1993
- Color flow Doppler characterization of focal hepatic lesions.American Journal of Roentgenology, 1992
- Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging.Radiology, 1992
- Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent.Radiology, 1990
- Color Doppler flow imaging of liver tumors.American Journal of Roentgenology, 1990
- Doppler color flow imagingJournal of Clinical Ultrasound, 1987
- Hepatic tumors: US contrast enhancement with CO2 microbubbles.Radiology, 1986